Article Detail

News & Knowledge

Lowndes Counsels Applied DNA on Its EUA-Authorized Linea™ COVID-19 Test Which FDA Lists as Being Able to Identify New U.K. Variant

January 20, 2021

Orlando, FL – Lowndes, a Florida-based law firm, has represented Applied DNA Sciences Inc. (NASDAQ: APDN) (Applied DNA) in relation to all Food and Drug Administration (FDA) regulatory work for the company’s Linea™ COVID-19 Assay Kit, which was recently identified by the FDA as one of a select few EUA authorized molecular diagnostic  tests able to detect certain mutations in COVID-19, including the UK variant known as B.1.1.7. Lowndes attorney Clay D. Shorrock advised Applied DNA throughout the original EUA process, which was awarded in May 2020, and has continued to work with the company in expanding the scope of the EUA. Shorrock provided counsel to Applied DNA throughout the rigorous EUA process, including drafting FDA submissions and representing Applied DNA in FDA interactions, as well as preparing necessary patent applications.

“We believe our Assay Kit can give public health officials and diagnostic laboratories a fast and cost-efficient tool – whether through diagnostic or pooled surveillance testing – with which to potentially identify and track B.1.1.7 spread that is made all the more challenging by the variant’s apparent transmission advantage,” said Dr. James A. Hayward, president and CEO, Applied DNA, in a written release.

Coincidently, Shorrock also advised Applied DNA on all intellectual property related matters in support of a $15M registered direct offering.

About Applied DNA Sciences 

Applied DNA is a provider of molecular technologies that enable nucleic acid-based therapeutic and diagnostic candidates, supply chain security, anti-counterfeiting and anti-theft technology, and product genotyping.

About Lowndes 

Founded in Orlando, Florida in 1969, Lowndes, Drosdick, Doster, Kantor & Reed, P.A., is a multi-discipline business law firm. Our attorneys represent corporate, entrepreneurial and individual clients across a myriad of industries locally, nationally and beyond our borders, from offices in Orlando, Mount Dora and Melbourne, and through Meritas, an established global alliance of independent law firms offering local insight, local rates and world-class client service. LOCAL ROOTS. BROAD REACH.℠


Clay Shorrock focuses his practice on business and IP transactions, corporate law and governance, securities law, and mergers and acquisitions.

Clay is also a registered patent attorney and practices in the areas of patent prosecution, due diligence, IP portfolio management and patent infringement and validity determinations, with extensive experience in the areas of biotechnology, pharmaceuticals, genetic engineering, molecular biology, immunotherapy, medical devices, software, medical diagnostics, mechanical devices and communications.

Previously, Clay was general and IP counsel to a Nasdaq listed biotechnology company and worked for several well-known New York and New Jersey law firms where he represented clients ranging from Fortune 500 companies to nascent high-tech start-ups.

A New York native, Clay and his family have made sunny Orlando their adopted home.

Meritas Law Firms Worldwide logo
Do Your Part Logo